Literature DB >> 7515407

Optimization for the detection of hepatitis C virus antigens in the liver.

R P González-Peralta1, J W Fang, G L Davis, R Gish, K Tsukiyama-Kohara, M Kohara, M U Mondelli, R Lesniewski, M I Phillips, M Mizokami.   

Abstract

To optimize the detection of hepatitis C viral antigens in liver tissue, cryostat and formalin-fixed, paraffin-embedded liver sections from 21 patients with chronic hepatic C viral infection were studied. For cryostat sections, six different fixatives were compared. Sixteen primary antibodies were tested: nine different mouse monoclonal anti-hepatitis C virus-core antibodies, a human monoclonal anti-hepatitis C virus-non-structural 4, and six rabbit polyclonals directed against synthetic peptides of the hepatitis C virus core, envelope, and non-structural 3, non-structural 4, non-structural 5. Three detection systems, 3- and 5-step peroxidase-antiperoxidase and avidin-biotin complex, were examined. In cryostat sections, acetone/chloroform formation consistently produced the best signal-to-background ratio. Five anti-hepatitis C virus-core monoclonals which recognize amino acid sequence 26-45 of the hepatitis C virus-core region consistently detected the viral antigen, but not the monoclonals directed against 39-74 of the hepatitis C virus-core region. The human anti-hepatitis C virus-non-structural 4, which reacts to amino acid sequence 1700-1705, also regularly detected viral antigen. The rabbit polyclonals produced either negative or nonspecific staining. The 5-step peroxidase-antiperoxidase provided the strongest signal and the avidin-biotin system produced high background consistently. Overall, hepatitis C virus core and non-structural 4 antigens were detected in 71% and 57% of the patients studied. Of the 16 patients seropositive for hepatitis C virus RNA, 75% and 69% had detectable hepatitis C virus core and non-structural 4, in contrast to 60% and 20% of the five hepatitis C virus RNA seronegative patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515407     DOI: 10.1016/s0168-8278(05)80481-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Characterization of a panel of monoclonal antibodies and mapping the epitopes of hepatitis C virus proteins.

Authors:  O V Masalova; A G Abdulmedzhidova; S N Atanadze; E I Lakina; YuA Semiletov; A N Burkov; T I Ulanova; V V Novikov; V K Pimenov; G Filds; YuE Khudyakov; A A Kushch
Journal:  Dokl Biochem Biophys       Date:  2002 Mar-Apr       Impact factor: 0.788

Review 2.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.

Authors:  P Maillard; K Krawczynski; J Nitkiewicz; C Bronnert; M Sidorkiewicz; P Gounon; J Dubuisson; G Faure; R Crainic; A Budkowska
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C.

Authors:  R P González-Peralta; J W Fang; G L Davis; R G Gish; M Kohara; M U Mondelli; M S Urdea; M Mizokami; J Y Lau
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

5.  Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminases.

Authors:  Yahia Z Gad; Narres Mouas; Azza Abdel-Aziz; Nashwa Abousmra; Mona Elhadidy
Journal:  Asian J Transfus Sci       Date:  2012-01

6.  Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation.

Authors:  F Fenwick; M F Bassendine; K Agarwal; D Bevitt; W Pumeechockchai; A D Burt; G L Toms
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

7.  Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.

Authors:  Medhat K Shier; Mohammad S El-Wetidy; Hebatallah H Ali; Mohammad M Al-Qattan
Journal:  Saudi J Gastroenterol       Date:  2016 May-Jun       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.